CREDIT SUISSE AG/ - ADAPTIVE BIOTECHNOLOGIES COR ownership

ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 209 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q3 2020. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of ADAPTIVE BIOTECHNOLOGIES COR
ValueSharesWeighting
Q3 2023$695,208
-21.9%
127,561
-3.9%
0.00%0.0%
Q2 2023$890,645
-17.7%
132,734
+8.3%
0.00%0.0%
Q1 2023$1,082,567
+19.4%
122,601
+3.3%
0.00%0.0%
Q4 2022$906,799
+29.5%
118,691
+20.6%
0.00%0.0%
Q3 2022$700,000
-4.4%
98,387
+8.7%
0.00%0.0%
Q2 2022$732,000
-39.9%
90,513
+3.1%
0.00%0.0%
Q1 2022$1,218,000
-44.1%
87,793
+13.2%
0.00%0.0%
Q4 2021$2,177,000
-26.5%
77,567
-10.9%
0.00%
-50.0%
Q3 2021$2,960,000
-14.2%
87,086
+3.1%
0.00%0.0%
Q2 2021$3,450,000
+7.6%
84,430
+6.0%
0.00%0.0%
Q1 2021$3,207,000
-22.5%
79,663
+13.8%
0.00%0.0%
Q4 2020$4,139,000
+27.0%
69,988
+4.5%
0.00%0.0%
Q3 2020$3,258,000
-53.4%
66,993
-53.6%
0.00%
-60.0%
Q2 2020$6,992,000
+3049.5%
144,527
+1705.7%
0.01%
Q1 2020$222,000
-92.5%
8,004
-86.9%
0.00%
-100.0%
Q2 2019$2,946,00061,0000.00%
Other shareholders
ADAPTIVE BIOTECHNOLOGIES COR shareholders Q3 2020
NameSharesValueWeighting ↓
Blue Water Life Science Advisors, LP 3,030,434$23,152,51615.55%
BERYLSON CAPITAL PARTNERS, LLC 289,726$2,213,5076.45%
Matrix Capital Management Company, LP 11,572,590$88,414,5881.69%
Pier Capital, LLC 1,012,401$7,734,7441.27%
VIKING GLOBAL INVESTORS LP 29,993,708$229,151,9291.15%
Eagle Health Investments LP 607,860$4,644,0501.07%
Triatomic Management LP 130,805$999,3500.84%
Aristotle Atlantic Partners, LLC 1,880,567$14,367,5320.80%
Senator Investment Group LP 1,000,000$7,640,0000.69%
ARK Investment Management 9,201,245$70,297,5120.61%
View complete list of ADAPTIVE BIOTECHNOLOGIES COR shareholders